Skip to search formSkip to main contentSkip to account menu

ACU-4429

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

emixustat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A Phase 2 Double-masked, Placebo-controlled, Dose Ranging Study of Emixustat Hydrochloride (ACU-4429) in Subjects with GA Associated with Dry AMD
2012
2012
Prolonged Rod Visual Cycle Suppression with ACU-4429 in Patients with Geographic Atrophy
2012
2012
A Phase I Dose-Ranging Study of ACU-4429, a Novel Visual Cycle Modulator, in Healthy Volunteers
Review
2010
Review
2010
FDA Pipeline preview, April 2010 (Miglustat, Insulin human inhalation powder, APF530, Exenatide LAR, Pirfenidone, ACU-4429, L-asparaginase, Alpha1-proteinase inhibitor, LIPO-102, QPI-1002/I5NP, MA09…
Recent FDA action (through March 2010) related to Miglustat, Insulin human inhalation powder, APF530, Exenatide LAR, Pirfenidone… 
2009
2009
Phase 1, Dose-Escalating Study of the Safety, Tolerability, and Pharmacokinetics of ACU-4429 in Healthy Volunteers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)